Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - STOCK-BASED COMPENSATION
Stock-based Compensation IBRX - ImmunityBio, Inc.
49.2 M
LAST VALUE
-7.28%
2 YEAR CAGR
88.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR